A variant in MCF2L is associated with osteoarthritis

105Citations
Citations of this article
134Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Osteoarthritis (OA) is a prevalent, heritable degenerative joint disease with a substantial public health impact. We used a 1000-Genomes-Project-based imputation in a genome-wide association scan for osteoarthritis (3177 OA cases and 4894 controls) to detect a previously unidentified risk locus. We discovered a small disease-associated set of variants on chromosome 13. Through large-scale replication, we establish a robust association with SNPs in MCF2L (rs11842874, combined odds ratio [95% confidence interval] 1.17 [1.11-1.23], p = 2.1 × 10-8) across a total of 19,041 OA cases and 24,504 controls of European descent. This risk locus represents the third established signal for OA overall. MCF2L regulates a nerve growth factor (NGF), and treatment with a humanized monoclonal antibody against NGF is associated with reduction in pain and improvement in function for knee OA patients. © 2011 The American Society of Human Genetics.

Cite

CITATION STYLE

APA

Day-Williams, A. G., Southam, L., Panoutsopoulou, K., Rayner, N. W., Esko, T., Estrada, K., … Zeggini, E. (2011). A variant in MCF2L is associated with osteoarthritis. American Journal of Human Genetics, 89(3), 446–450. https://doi.org/10.1016/j.ajhg.2011.08.001

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free